LONDON--(BUSINESS WIRE)--Technavio’s global implantable cardioverter defibrillators (ICD) market research report forecasts the market to grow at a CAGR of almost 2% during the forecast period. The ...
Boston Scientific has begun a clinical trial of its first modular cardiac rhythm implant system. It consists of a leadless pacemaker and an implantable cardioverter defibrillator—two separate devices ...
Background: Although more than 150,000 implantable cardioverter defibrillators (ICDs) are implanted yearly worldwide, only few studies systematically examined complications of ICD therapy in large ...
The purpose of this paper is to describe how a selected group of United States patients with an implantable cardioverter-defibrillator perceived their life situation. A qualitative design based on the ...
This news comes amid a push within value-based care to ensure high-cost medical interventions deliver meaningful improvements ...
A standard test of the implantable cardioverter defibrillator (ICD) is linked to significant thought-processing problems that improve for most patients within a year after the device is inserted, ...
Add Yahoo as a preferred source to see more of our stories on Google. In this undated image provided by the Jewish National Fund-USA, Dr. Morton Mower and his wife, Toby, pose for a picture. Dr.
Implantable cardioverter–defibrillators (ICDs) prevent sudden death from cardiac causes in selected patients but require the use of transvenous lead systems. To eliminate the need for venous access, ...
The indications for ICD implantation continue to expand; however, these devices are associated with complications related to the implantation procedure itself and morbidity caused by the normal and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results